載入...
Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity
The incidence of metabolic syndrome continues to rise globally. In mice, intravenous administration of interleukin-22 (IL-22) ameliorates various disease phenotypes associated with diet-induced metabolic syndrome. In patients, oral treatment is favored over intravenous treatment, but methodologies t...
Na minha lista:
| 發表在: | mSphere |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316485/ https://ncbi.nlm.nih.gov/pubmed/32581074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00183-20 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|